
Federal Trade Commission Chair Lina Khan announced an open meeting of the Commission will be held virtually on Thursday, July 1, 2021. This will be the first of a series of monthly meetings that will open the work of the Commission to the public. The open meeting will begin at 12 pm ET, and will be followed by a time for members of the public to address the Commission.
The following items will be on the tentative agenda for the July 1 event:
Business Before the Commission
Made in the USA Rule: The Commissioners will vote on whether to finalize the Made in the USA Rule. The rule would help ensure that consumers can confidently buy American, and that honest companies can realize the benefits of the Made in USA label.
Section 18 Rulemaking Procedures: The Commissioners will vote on whether to streamline the procedures for Section 18 rules prohibiting unfair or deceptive acts or practices. Section 18 rules allow the Commission to seek redress for defrauded consumers and penalties against firms that cheat.
“Statement of Enforcement Principles Regarding ‘Unfair Methods of Competition’ Under Section 5 of the FTC Act” (2015): The Commissioners will vote on whether to rescind the policy statement issued by the Commission in 2015 in order to better align with the requirements set out by Congress to condemn “unfair methods of competition.”
Enforcement Investigations: The Commissioners will vote on whether to approve a series of resolutions that will streamline investigations by Commission staff into specific industries or specific conduct. The resolutions would provide ongoing authority for a single Commissioner to approve the use of compulsory process in those investigations.
Public Comments
After conducting its business, the Commission will invite members of the public to share feedback on the Commission’s work generally and bring relevant matters to the Commission’s attention.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas